StonvexLoading…
StonvexStonvexStonvexCore line items from USIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $85.39M | $82.93M | $84.07M | $69.43M |
Operating Income | $-2.36M | $-1.47M | $-447.36K | $-5.21M |
Net Income | $-2.51M | $3.31M | $-475.10K | $-5.48M |
EPS (Diluted) | $-0.09 | $0.12 | $-0.02 | $-0.27 |
Total Assets | $134.89M | $107.21M | $106.93M | $97.91M |
Total Liabilities | $116.98M | $88.05M | $91.87M | $83.98M |
Cash & Equivalents | $7.43M | $8.06M | $7.16M | $5.71M |
Free Cash Flow OCF − CapEx | $1.08M | $2.70M | $2.67M | $-17.85M |
Shares Outstanding | 27.73M | 26.61M | 26.33M | 25.10M |